首页 | 本学科首页   官方微博 | 高级检索  
     

罗格列酮对2型糖尿病患者血压的影响
引用本文:汲宏磊,孔俭,王凤波. 罗格列酮对2型糖尿病患者血压的影响[J]. 中国老年学杂志, 2003, 23(8): 504-505
作者姓名:汲宏磊  孔俭  王凤波
作者单位:1. 吉林大学第一医院干部病房,吉林,长春,130021
2. 黑龙江省绥化市第一人民医院
摘    要:目的 观察胰岛素增敏剂罗格列酮治疗2型糖尿病伴高血压患者,评价其降压作用,探讨其降压机理。方法 32例2型糖尿病患者按血压分组,口服罗格列酮(文迪雅)4~8mg/d,共8w,计算胰岛素敏感指数和抵抗指数。结果 罗格列酮分别降低了两组的血压水平,胰岛素敏感指数升高,抵抗指数降低。结论 罗格列酮治疗2型糖尿病伴有高血压的患者的时候,在降低血浆胰岛素水平、改善IR的同时,能够明显降低血压。

关 键 词:罗格列酮 2型糖尿病 血压 胰岛素增敏剂 胰岛素抵抗 高胰岛素血症
文章编号:1005-9202(2003)08-0504-02
修稿时间:2002-08-10

Effects of rosiglitazone on blood pressure in patients with type 2 diabetes
JI Hong lei,KONG Jian,WANG Feng bo.. Effects of rosiglitazone on blood pressure in patients with type 2 diabetes[J]. Chinese Journal of Gerontology, 2003, 23(8): 504-505
Authors:JI Hong lei  KONG Jian  WANG Feng bo.
Abstract:Objective To investigate the effects of insulin sensitizer (Rosiglitazone) on blood pressure in type 2 diabetic patients.Methods 32 type 2 diabetes were divided into two groups according their blood pressure. All patients received orally rosiglitazone 4 8mg/d for 8 weeks. The major indexes are insulin resistance index and HOMA IR.Results Rosiglitazone could lower the blood pressure in two groups seperately, and increase the ISI and decrcease HOMA IR.Conclusions Rosiglitazone can lower level of blood glucose and insulin, improve insulin sensitivity, and decrease BP as well.
Keywords:Insulin resistance Hypertension Insulin sensitizer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号